Caribou Biosciences is a leading clinical-stage CRISPR genome editing biotechnology company founded by pioneers of CRISPR biology and located in Berkeley, CA. The company is developing an internal pipeline of off-the-shelf, genome-edited CAR-T and natural killer (NK) cell therapies. 

Biotechnology

Caribou Biosciences

Caribou Biosciences' headquarters in Berkeley, CA, United States

Rachel Haurwitz

Steven Kanner

Sri Ryali

Elaine Alambra

Marie Velasco

Reigin Zawadzki

Tim Kelly

Ruhi Khan

Barbara Mcclung

David Johnson

Christopher Sturgeon

Noopur Raje

Cameron Turtle

Jeffrey Rathmell

Ami Bhatt

Martin Jinek

Natalie Sacks

Sriram Krishnaswami

Jennifer Doudna

Stephen J. Schuster

Nancy Whiting

Andrew Guggenhime

Dara Richardson-Heron

Scott Braunstein

Ran Zheng

Katy Rezvani

The Clinical and Research Team at Caribou Biosciences is responsible for advancing the company's pipeline of genome-edited CAR-T and NK cell therapies through rigorous clinical trials and research. This team integrates clinical development strategies, oversees research operations, and ensures the generation and analysis of critical data to support the safety and efficacy of innovative therapies. By collaborating across disciplines, they drive the translation of groundbreaking CRISPR technologies into transformative patient treatments.

Clinical and Research Team

The Medical Affairs Team at Caribou Biosciences plays a crucial role in bridging scientific innovation with clinical application. They provide expert medical and scientific support for the development of genome-edited therapies, facilitate communication between the company and healthcare professionals, and ensure compliance with safety regulations. Their collaborative efforts are essential for advancing the understanding and adoption of cutting-edge CAR-T and NK cell therapies within the medical community.

Medical Affairs Team

The Operations and Finance Team at Caribou Biosciences ensures the efficient functioning of the company's financial and operational systems. This team is responsible for overseeing financial reporting, budgeting, and compliance, while also managing technical operations and information technology to support the development of innovative genome editing therapies. Their collaborative efforts streamline processes, optimize resource allocation, and drive strategic initiatives to support the company's growth in the biotechnology sector.

Operations and Finance Team

The Leadership Team at Caribou Biosciences is responsible for setting the strategic direction and ensuring the operational success of the company. This diverse team oversees critical functions such as legal affairs, regulatory compliance, finance, human resources, and technical operations, while fostering collaboration among scientific and research initiatives. Their collective expertise drives the development of innovative genome-edited therapies, shaping the future of CRISPR-based treatments in clinical applications.

Leadership Team

The Quality Assurance and Compliance Team at Caribou Biosciences ensures that all processes and products meet stringent regulatory standards and quality benchmarks. This team is responsible for implementing and overseeing good manufacturing practices (GMP), conducting audits, and ensuring compliance with regulatory requirements throughout the development of genome-edited therapies. Their expertise is vital for maintaining the integrity and safety of the company’s innovative CAR-T and NK cell therapies.

Quality Assurance and Compliance Team

Caribou Biosciences

Org chart

Board & advisors

Teams

Clinical and Research Team

Medical Affairs Team

Operations and Finance Team

Leadership Team

Quality Assurance and Compliance Team

Offices

Caribou Biosciences

Org chart

Board & advisors

Teams

Clinical and Research Team

Medical Affairs Team

Operations and Finance Team

Leadership Team

Quality Assurance and Compliance Team

Offices

Related companies